Oliver Illini, Specialist in Internal Medicine and Pulmonology at Wiener Gesundheitsverbund, shared on LinkedIn:
“Delighted to share that our article has been selected as the Journal of Thoracic Oncology (JTO) Editor’s Choice for July 2026!
Our multicenter TRACER/HERTras real-world study reports the systemic and intracranial efficacy and safety of trastuzumab deruxtecan in patients with HER2-mutant NSCLC across treatment lines.
Many thanks to all co-authors, investigators and collaborators. Special thanks to my team at Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie and Wiener Gesundheitsverbund, and the JTO / International Association for the Study of Lung Cancer for highlighting our work as this month’s Editor’s Choice.”
Title: Systemic and Intracranial Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Mutant NSCLC Across Treatment Lines: Evidence From the TRACER/HERTras Real-World Cohort
Authors: Oliver Illini, Anna-Carina Hund, Hans-Georg Kopp, Mor Moskovitz, Giannis Mountzios, Wolfgang M. Brueckl, Martin Früh, Marie-Elisabeth Leßmann, Petros Christopoulos, Albrecht Stenzinger, Michael Thomas, Roni Gillis, Nir Peled, Fabian Acker, Alfredo Addeo, Andriani Charpidou, Christian Grohé, Horst-Dieter Hummel, Laetitia Mauti, Sacha I. Rothschild, Sabine Schmid, Christian Schumann, Damien Urban, Robert Wurm, Simon Ekman, Marcus Skribek, Franziska Glanemann, Marcel Wiesweg, Christoph Jakob Ackermann, Sofia Agelaki, Petra Hoffknecht, Marko Jakopović, Jens Kern, David König, Katharina Kostenzer, Cornelia Kropf-Sanchen, Eckart Laack, David Lang, Laurenz Nagl, Georg Pall, Martin Reck, Waleed Kian, Anna T. Allemann, Jürgen Alt, David Araújo, Hanibal Bohnenberger, Alexandros Bokas, Hannah Fabikan, Krainer-Jacobs Julie, Christoph Weinlinger, Adrianus Johannes de Langen, Evangelos Georgios Fergadis, Rieke Fischer, Elena Fountzilas, Patrizia Froesch, Nikolaj Frost, Frank Griesinger, Franziska Jordan, Charisios Karanikiotis, Barbara Kiesewetter, Ippokratis Korantzis, Andrea Lopes Machado, Panagiota Economopoulou, Arnold Pilz, Patrick Reimann, Achim Rittmeyer, Akram Saad, Konstantinos Samitas, Karsten Schulmann, Riyaz Shah, Jan Alexander Stratmann, Hossein Taghizadeh, Kai Tammoscheit, Amanda Tufman, Jan-Phillip Weber, Ewald Wöll, Arschang Valipour, Tobias R. Overbeck, Maximilian J. Hochmair.
Read the full article.
To which Martin Reck, Head of Department at LungenClinic Grosshansdorf, added:
“Thank you for your commitment to put this important piece of real world evidence together and thank you for the invitation to participate.
You might be interested in:
Izalontamab Brengitecan Shows Encouraging Activity in Relapsed ES-SCLC
